Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|July 11, 2014
RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phaseHong Hu, Jun Wang, Akash Gupta, et al.
Trials|December 21, 2019
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)Elizabeth Ahern, Annette Cubitt, Emma Ballard, et al.
Urologic Oncology|September 2, 2018
Receptor activator of NF-κB (RANK)-mediated induction of metastatic spread and association with poor prognosis in renal cell carcinomaAndré Steven, Sandra Leisz, Sebastian Fussek, et al.
Breast Cancer Research and Treatment|April 17, 2014
RANK expression as a prognostic and predictive marker in breast cancerBerit Maria Pfitzner, Daniel Branstetter, Sibylle Loibl, et al.
Oncoimmunology|May 4, 2018
CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activityAmelia Roman Aguilera, Viviana P Lutzky, Deepak Mittal, et al.
Asia-Pacific Journal of Clinical Oncology|April 9, 2026
Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 TrialElizabeth Ahern, Cassie Turner, Rishendran Naidoo, et al.
Cancer Research|August 3, 2016
RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell DifferentiationGuillermo Yoldi, Pasquale Pellegrini, Eva M Trinidad, et al.
Molecular Cancer Therapeutics|June 2, 2007
Detection of myeloma in skeleton of mice by whole-body optical fluorescence imagingBabatunde O Oyajobi, Steve Muñoz, Rami Kakonen, et al.
Leukemia|December 20, 2022
Inhibition of CD39 unleashes macrophage antibody-dependent cellular phagocytosis against B-cell lymphomaMika Casey, Kane Segawa, Soi Cheng Law, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2002
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesisLisa M Childs, Eleftherios P Paschalis, Lianping Xing, et al.
Pageof 7